Predictors of Axial Pain Improvement After Anterior Cervical Discectomy and Fusion
Launched by MEDICAL UNIVERSITY OF WARSAW · Sep 14, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a surgery called anterior cervical discectomy and fusion (ACDF) helps reduce neck pain in patients with certain neck issues, like cervical spondylosis and cervical disc disease. While ACDF is commonly used for treating problems that affect the spinal cord or nerves, researchers want to better understand which patients specifically see improvement in their neck pain after the surgery.
To participate in the study, candidates need to be between 65 and 74 years old and must be eligible for ACDF. This means they should be dealing with neck problems that could be helped by this surgery. However, individuals who have had previous neck surgeries, suffered serious neck injuries, or have certain medical conditions that cause neck pain, like arthritis or fibromyalgia, cannot join. If you participate, you can expect to be monitored for changes in your neck pain and how well you respond to the surgery. Your input will help doctors understand which patients may benefit the most from this procedure in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ability to provide informed consent
- • Patients who are qualified for one- or two-level ACDF for the treatment of degenerative cervical pathology
- Exclusion Criteria:
- • Previous cervical spine surgery
- • Previous cervical spine trauma
- • Other diseases causing neck pain include rheumatoid arthritis, lupus, polymyalgia rheumatica, myositis, seronegative inflammatory diseases, and fibromyalgia
- • Drug abuse
- • Myelopathy
- • Spinal infection
- • VAS neck pain score less than 3 (Inability to achieve an MCID which is calculated as 2.5 for the VAS scale)
About Medical University Of Warsaw
The Medical University of Warsaw is a leading academic institution dedicated to advancing healthcare through innovative research and education. Renowned for its commitment to excellence in medical training and clinical practice, the university actively engages in a diverse range of clinical trials aimed at improving patient outcomes and enhancing medical knowledge. With a robust infrastructure and a multidisciplinary team of experts, the Medical University of Warsaw fosters collaboration in the development of novel therapies and interventions, contributing significantly to the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kraków, Lesser Poland Voivodeship, Poland
Warsaw, Masovian, Poland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported